Clinical Characteristics of Nocardiosis: a Multicenter Retrospective Study in Korea.

IF 2.8 Q2 INFECTIOUS DISEASES
Infection and Chemotherapy Pub Date : 2023-12-01 Epub Date: 2023-08-04 DOI:10.3947/ic.2023.0032
Seulki Kim, Hye Jin Shi, Cheon-Hoo Jeon, Sun Bean Kim, Jongyoun Yi, A Reum Kim, Kye-Hyung Kim, Seungjin Lim
{"title":"Clinical Characteristics of Nocardiosis: a Multicenter Retrospective Study in Korea.","authors":"Seulki Kim, Hye Jin Shi, Cheon-Hoo Jeon, Sun Bean Kim, Jongyoun Yi, A Reum Kim, Kye-Hyung Kim, Seungjin Lim","doi":"10.3947/ic.2023.0032","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Nocardiosis is a rare, but potentially life-threatening condition. It is difficult to diagnose, and bacterial culture identification can be time consuming. We investigated the characteristics of nocardiosis and the suitability of the treatment approach in Korea.</p><p><strong>Materials and methods: </strong>This retrospective study was conducted at 5 medical institutions between 2011 and 2021. We reviewed the medical records of patients with microbiologically confirmed nocardiosis. Appropriate antibiotic selection was defined as follows: (1) selecting antibiotics according to the species, (2) if the species of <i>Nocardia</i> was unknown, trimethoprim-sulfamethoxazole-based therapy or linezolid-based therapy was administered, and (3) selection of antibiotics using the antibiotic susceptibility test. The appropriate treatment periods for antibiotics were defined as treatment maintained from 3 to 12 months, depending on involvement of the organs. Descriptive analysis and Fisher exact test were used. Statistical significance was set at <i>P</i>-values of <0.05.</p><p><strong>Results: </strong>Thirty patients were enrolled. Of these patients, 18 (60.0%) were male. The median age was 70.5 years. Among the diagnosed patients, 12 (40.0%) had an immunocompromised status. Eight (30.0%) patients received optimal treatment for the appropriate treatment period. Appropriate dosing duration was observed in 3 of the 12 (25.0%) immunocompromised patients. There was no significant difference between the presence or absence of immunosuppression and the adequacy of treatment for nocardiosis (<i>P</i> = 1.000). Skin and soft tissue (14 patients) were most frequently involved in this study. <i>Nocardia</i> species (spp.) were isolated from culture at a median of 6.0 days. There were 7 cases with <i>N. farcinica</i> (23.3%).</p><p><strong>Conclusion: </strong>We found that 60.0% of the patients with nocardiosis did not have an immunocompromised status. Further, 26.7% of the total patients received adequate treatment for nocardiosis. The reasons for suboptimal management of nocardiosis in Korea are presumed to be diagnostic difficulties, lack of awareness about nocardiosis, and difficulties in selecting antibiotics for <i>Nocardia</i> spp. among clinicians. The lack of antibiotic susceptibility tests for <i>Nocardia</i> spp. could be the source of these problems. Nocardiosis should be suspected in cases of recurrent infections with skin and soft tissue, musculoskeletal, or respiratory system involvement with or without an immunocompromised status. Clinical microbiological support is required for the diagnosis and selection of antibiotics in Korea. High clinical index of suspicion and clinical microbiological support are required for the accurate diagnosis of nocardiosis in Korea.</p>","PeriodicalId":51616,"journal":{"name":"Infection and Chemotherapy","volume":" ","pages":"431-440"},"PeriodicalIF":2.8000,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10771949/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Infection and Chemotherapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3947/ic.2023.0032","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/8/4 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Nocardiosis is a rare, but potentially life-threatening condition. It is difficult to diagnose, and bacterial culture identification can be time consuming. We investigated the characteristics of nocardiosis and the suitability of the treatment approach in Korea.

Materials and methods: This retrospective study was conducted at 5 medical institutions between 2011 and 2021. We reviewed the medical records of patients with microbiologically confirmed nocardiosis. Appropriate antibiotic selection was defined as follows: (1) selecting antibiotics according to the species, (2) if the species of Nocardia was unknown, trimethoprim-sulfamethoxazole-based therapy or linezolid-based therapy was administered, and (3) selection of antibiotics using the antibiotic susceptibility test. The appropriate treatment periods for antibiotics were defined as treatment maintained from 3 to 12 months, depending on involvement of the organs. Descriptive analysis and Fisher exact test were used. Statistical significance was set at P-values of <0.05.

Results: Thirty patients were enrolled. Of these patients, 18 (60.0%) were male. The median age was 70.5 years. Among the diagnosed patients, 12 (40.0%) had an immunocompromised status. Eight (30.0%) patients received optimal treatment for the appropriate treatment period. Appropriate dosing duration was observed in 3 of the 12 (25.0%) immunocompromised patients. There was no significant difference between the presence or absence of immunosuppression and the adequacy of treatment for nocardiosis (P = 1.000). Skin and soft tissue (14 patients) were most frequently involved in this study. Nocardia species (spp.) were isolated from culture at a median of 6.0 days. There were 7 cases with N. farcinica (23.3%).

Conclusion: We found that 60.0% of the patients with nocardiosis did not have an immunocompromised status. Further, 26.7% of the total patients received adequate treatment for nocardiosis. The reasons for suboptimal management of nocardiosis in Korea are presumed to be diagnostic difficulties, lack of awareness about nocardiosis, and difficulties in selecting antibiotics for Nocardia spp. among clinicians. The lack of antibiotic susceptibility tests for Nocardia spp. could be the source of these problems. Nocardiosis should be suspected in cases of recurrent infections with skin and soft tissue, musculoskeletal, or respiratory system involvement with or without an immunocompromised status. Clinical microbiological support is required for the diagnosis and selection of antibiotics in Korea. High clinical index of suspicion and clinical microbiological support are required for the accurate diagnosis of nocardiosis in Korea.

诺卡氏菌病的临床特征:韩国一项多中心回顾性研究。
背景:诺卡氏杆菌病是一种罕见但可能危及生命的疾病。它很难诊断,细菌培养鉴定也很费时。我们调查了韩国诺卡氏菌病的特点和治疗方法的适用性:这项回顾性研究于 2011 年至 2021 年期间在 5 家医疗机构进行。我们查阅了经微生物学确诊的念珠菌病患者的病历。适当选择抗生素的定义如下:(1)根据菌种选择抗生素;(2)如果诺卡菌菌种不明,则采用三甲双胍-磺胺甲恶唑治疗或利奈唑胺治疗;(3)使用抗生素药敏试验选择抗生素。根据受累器官的不同,抗生素的适当治疗期为 3 至 12 个月。采用描述性分析和费雪精确检验。统计意义以 P 值为标准:共招募了 30 名患者。其中 18 人(60.0%)为男性。年龄中位数为 70.5 岁。在确诊的患者中,12 人(40.0%)免疫力低下。8名患者(30.0%)在适当的治疗期内接受了最佳治疗。在 12 名(25.0%)免疫力低下的患者中,有 3 人(25.0%)接受了适当的用药时间。是否存在免疫抑制与治疗诺卡菌病的充分性之间没有明显差异(P = 1.000)。在本研究中,皮肤和软组织(14 名患者)最常受累。从培养物中分离出诺卡氏菌(属)的时间中位数为 6.0 天。结论:我们发现,60.0%的患者感染了诺卡氏菌(Nocardia):我们发现,60.0%的诺卡菌病患者没有免疫力低下的情况。此外,26.7%的患者接受了适当的诺卡菌病治疗。韩国对诺卡氏菌病的治疗效果不佳的原因被认为是诊断困难、缺乏对诺卡氏菌病的认识,以及临床医生在为诺卡氏菌属选择抗生素时遇到困难。缺乏针对诺卡氏杆菌的抗生素药敏试验可能是这些问题的根源。无论是否存在免疫力低下的情况,如果出现皮肤和软组织、肌肉骨骼或呼吸系统受累的复发性感染,都应怀疑是诺卡氏杆菌病。在韩国,诊断和选择抗生素需要临床微生物学支持。在韩国,准确诊断诺卡菌病需要高度的临床怀疑指数和临床微生物学支持。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Infection and Chemotherapy
Infection and Chemotherapy INFECTIOUS DISEASES-
CiteScore
6.60
自引率
11.90%
发文量
71
审稿时长
22 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信